Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:interferon_beta-1b
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration 2009 |
| gptkbp:associatedWith |
gptkb:Betaseron
|
| gptkbp:ATCCode |
gptkb:L03AB08
|
| gptkbp:form |
powder for solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Extavia
|
| gptkbp:indication |
relapsing-remitting multiple sclerosis
clinically isolated syndrome |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
injection site reaction
flu-like symptoms liver enzyme elevation |
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:Betaseron
|
| gptkbp:bfsLayer |
6
|